QuantaMatrix Inc. (317690.KQ)
- Previous Close
3,695.00 - Open
3,700.00 - Bid 3,640.00 x --
- Ask 3,650.00 x --
- Day's Range
3,600.00 - 3,700.00 - 52 Week Range
3,550.00 - 23,700.00 - Volume
29,237 - Avg. Volume
180,823 - Market Cap (intraday)
65.821B - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases. QuantaMatrix Inc. was founded in 2010 and is based in Seoul, South Korea.
www.quantamatrix.comRecent News: 317690.KQ
View MorePerformance Overview: 317690.KQ
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 317690.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 317690.KQ
View MoreValuation Measures
Market Cap
66.82B
Enterprise Value
70.38B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.46
Price/Book (mrq)
10.23
Enterprise Value/Revenue
28.18
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-40.78%
Return on Equity (ttm)
-163.64%
Revenue (ttm)
2.5B
Net Income Avi to Common (ttm)
-20.17B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
13.11B
Total Debt/Equity (mrq)
255.33%
Levered Free Cash Flow (ttm)
-10.8B